Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours

International Journal of Oncology

Volumn 12, Issue 3, 1998, Pages 597-601

  Mimori, Koshi ^a   Mori, Masaki ^a   Shiraishi, Takeshi ^a   Tanaka, Shinji ^a   Haraguchi, Masaru ^a   Ueo, Hiroaki ^b   Shirasaka, Chiaki ^b   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Breast cancer; c myc; Estradiol; Ornithine decarboxylase; Reverse transcriptase polymerase chain reaction

Indexed keywords

MESSENGER RNA; ORNITHINE DECARBOXYLASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 0031882534     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.3.597     Document Type: Article

References (35)

1. Auvinen M, Paasinen A, Andersson LC and Holtta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355-358, 1992.
2. Hibshoosh H, Johnson M and Weinstein IB: Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene 6: 739-743, 1991.
3. Moshier JA, Dosescu J, Skunca M and Luk GD: Transformation of NIH/3T3 cells by orinithine decarboxylase. Cancer Res 53: 2618-2622, 1993.
4. Shantz LM and Pegg AE: Overexpression of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 54: 2313-2316, 1994.
5. Russell D: Orinithine decarboxylase: A key reguratory enzyme in normal and neoplastic growth. Drug Metab Rev 16: 1-88, 1985.
6. Takano S, Matsushita M and Erturk G: Early induction of rat colonie epithelial ornithine and S-adenosyl L-methionine decarboxylase activities by N-methyl-N-nitrosoguanidine or bile salts. Cancer Res 41: 624-628, 1981.
7. Berdinkikh N, Ignatenko N, Zaletok S, Ganina K and Chorniy V: Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int J Cancer 47: 496-498, 1991.
8. Clifford A, Morgan D, Yuspa SH, Solar AP and Gilmour S: Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 55: 1680-1686, 1995.
9. Guillem JG, Levy MF, Hsieh LL, et al: Increased levels of Phorbin, c-myc and ornithine decarboxylase RNA in human colon cancer. Mol Carcinogen 3: 68-74, 1990.
10. Hietala OA, Yum KY, Pilon J, et al: Properties of orinithine decarboxylase in human colorectal adanocarcinomas. Cancer Res 50: 2088-2094, 1990.
11. Okuzumi J, Yamane T, Kitao Y, et al: Increased mucosal ornithine decarboxylase activity in human gastric cancer. Cancer Res 51: 1448-1451, 1991.
12. Yoshida M, Hayashi H, Taira M and Isono K: Elevated expression of the ornithine decarboxylase gene in human esophageal cancer. Cancer Res 52: 6671-6675, 1992.
13. Narayan S, Rajakumar G, Prouix H and Singh P: Estradiol is trophic for colon cancer in mice: effect on ornithine decarboxylase and c-myc messenger RNA. Gastroenterol 103: 1823-1832, 1992.
14. Hermanek P and Sobin LH: TNM Classification of Maligant Tumours. Springer-Verlag, Berlin, 1992.
15. Mori M, Barnard GF and Staniunus RJ: Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8: 2821-2826, 1993.
16. Mori M, Staniunus RJ, Barnard GF, Jessup JM, Steele GD and Chen LB: The significance of carbonic anhydrase expression in human colorectal cancer. Gastrocnterology 105: 820-826, 1993.
17. Mori M, Mimori K, Inoue H, et al: Detection of cancer micrometastasis in lymph nodes by reverse transcription-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
18. Mimori K, Mori M, Shiraishi T, Ueo H, Haraguchi M and Akiyoshi T: Clinical significance of pyrimidine nucleoside phosphorylase in colorectal carcinoma. Int J Oncol 10: 493-496, 1996.
19. Narisawa T, Takahashi M and Niwa M: Increased mucosal ornithine decarboxylase activity in large bowel with multiple tumors, adenocarcinoma and adenoma. Cancer 63: 1572-1576, 1989.
20. Nakanishi I, Sowa M, Kato Y, Chung Y-S and Otani S: Heterogeneity of ornithine decarboxylase activity in gastric cancer tissue. Oncologia 26: 697-701, 1993.
21. Luk G and Baylin S: Ornithine decarboxylase as a biological marker in familial colonie polyposis. N Eng J Med 311: 80-83, 1984.
22. Le Muraglia G: High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia. Ann Surg 204: 89-93, 1986.
23. Bravermann D: Ornithine decarboxylase: An unreliable marker for the identification of population groups at high risk for colonic neolplasia. Am J Gastroenterol 85: 723-725, 1990.
24. Porter C, Herrerra-Ornelas L and Pera P: Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues. Cancer 60: 1275-1281, 1987.
25. Westin T, Edstrom S, Lundholm K and Gustafsson B: Evaluation of ornithine decarboxylase activity as a marker for tumor growth rate in malignant tumors. Am J Surg 162: 288-293, 1991.
26. Mori M, Honda M, Shibuta K, et al: Expression of ornithine decarboxylase mRNA in gastric carcinoma. Cancer 77: 1634-1638, 1996.
27. Thomas T, Trend B, Butterfield J, et al: Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens. Cancer Res 49: 5852-5857, 1989.
28. Kubota S, Yamada T, Kamei S and Seyama Y: Ornithine decarboxylase is directly involved in mouse mammary carcinoma cell invasion in vitro. Biochem Biophys Res Commun 208: 1106-1115, 1995.
29. Bello-Fernandez C, Packham G and Cleveland JL: The ornithine decarboxylase gene is a trancriptional target of c-myc. Proc Natl Acad Sci USA 90: 7804-7808, 1993.
30. Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ: Oncogene protein co-expression. Value of Ha-ras, c-myc. c-fos. and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221: 706-718, 1995.
31. Gaffey MJ, Frierson HJ and Williams ME: Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Modern Pathol 6: 654-659, 1993.
32. Hehir DJ, McGreal G, Kirwan WO, Kealy W and Brady MP: c-myc oncogene expression: a marker for females at risk of breast carcinoma. J Surg Oncol 54: 207-209, 1993.
33. Maas RA, Bruning PF, Top B, Breedijk AJ and Peterse HL: Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response. Cancer Lett 97: 107-116, 1995.
34. Ottestad L, Andersen TI, Nesland JM, et al: Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis. Acta Oncol 32: 289-294, 1993.
35. Pavelic ZP, Pavelic L, Lower EE, et al: c-myc, c-erbE-2, and Ki-67 expression in normal breast tissue and in invasive and non-invasive breast carcinoma. Cancer Res 52: 2597-2602, 1992.